aminocaproic acid has been researched along with Atrial Septal Defect in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trinh-Duc, P | 1 |
| Wintrebert, P | 1 |
| Boulfroy, D | 1 |
| Albat, B | 1 |
| Thévenet, A | 1 |
| Roquefeuil, B | 1 |
1 trial available for aminocaproic acid and Atrial Septal Defect
| Article | Year |
|---|---|
[Comparison of the effects of epsilon-aminocaproic acid and aprotinin on intra- and postoperative bleeding in heart surgery].
Topics: Aminocaproic Acid; Aprotinin; Blood Loss, Surgical; Coronary Artery Bypass; Female; Heart Septal Def | 1992 |